Article Text

Download PDFPDF
Evaluation of vascular signal in pancreatic ductal carcinoma using contrast enhanced ultrasonography: effect of systemic chemotherapy
  1. A Kobayashi,
  2. T Yamaguchi,
  3. T Ishihara,
  4. H Tadenuma,
  5. K Nakamura,
  6. H Saisho
  1. Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan
  1. Correspondence to:
    Dr A Kobayashi
    Department of Medicine and Clinical Oncology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuou-ku, Chiba-shi, Chiba 260-8670, Japan; koninopar.odn.ne.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Evaluation of the effect of chemotherapy for pancreatic ductal cancer (PC) is generally conducted based on changes in tumour diameter using imaging modalities; however, exact measurement is often difficult because of local inflammation, fibrotic change, and desmoplastic reaction to treatment, leading to an unreliable evaluation.1,2 PC is considered a hypovascular tumour. However, newly developed highly sensitive ultrasonic equipment has enabled the detection of vascular signals in PC; vascular signals were detected in 20–67% of cases.3–7 We focused on changes in tumour vascularity of PC associated with chemotherapy, and attempted to apply it to evaluation of the effect of treatment and usefulness in relation to prognosis. In this study, we assessed vascular images of the tumour based on the Doppler signal (v signal) using contrast enhanced ultrasonography …

View Full Text